Morris Jeffrey Allen 4
4 · PROVECTUS BIOPHARMACEUTICALS, INC. · Filed Aug 14, 2024
Insider Transaction Report
Form 4
Morris Jeffrey Allen
10% Owner
Transactions
- Conversion
Series D-1 Convertible Preferred Stock
2024-08-12$2.86/sh+264,314$756,467→ 4,260,061 total
Holdings
- 12,000,000
Common Stock
- 6,500,000(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]The reporting person has sole voting and dispositive power over 12,000,000 shares of Common Stock.
- [F2]The reporting person has sole voting and dispositive power over 6,500,000 shares of Common Stock owned through an IRA retirement plan.
- [F3]The reporting person has sole voting and dispositive power over 4,260,061 shares of Series D-1 Convertible Preferred Stock, convertible into 42,600,610 shares of Common Stock.